The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults.

BDNF BHB cognition keto-adaptation ketogenic diet ketone salts mood sodium

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 16 06 2022
accepted: 22 08 2022
entrez: 17 10 2022
pubmed: 18 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Ketogenic diets are a commonly used weight loss method, but little is known how variations in sodium content and ketones influence cognition and mood during the early keto-adaptation period. To investigate the effects of an exogenous ketone salt (KS) as part of a hypocaloric KD on mood and cognitive outcomes in overweight and obese adults. A secondary objective was to evaluate changes in biochemical markers associated with inflammatory and cognitive responses. Adults who were overweight or obese participated in a 6-week controlled-feeding intervention comparing hypocaloric diets (∼75% of energy expenditure). KD groups received twice daily ketone salt (KD + KS; Both KD groups achieved nutritional ketosis. Fasting serum glucose decreased in both KD groups, whereas glucose was unaffected in the LFD. Insulin decreased at week 2 and remained lower in all groups. At week 2, depression scores in the KD + PL group were higher compared to KD + KS. Performance in the math processing and go/no-go cognitive tests were lower for KD + PL and LFD participants, respectively, compared to KD + KS. Serum leptin levels decreased for all groups throughout the study but were higher for KD + KS group at week 6. Serum TNF-α steadily increased for LFD participants, reaching significance at week 6. During a short-term hypocaloric diet, no indication of a consistent decline in mood or cognitive function were seen in participants following either KD, despite KD + PL being relatively low in sodium. WK2 scores of "anger" and "depression" were higher in the LFD and KD + PL groups, suggesting that KS may attenuate negative mood parameters during the early intervention stages.

Sections du résumé

Background UNASSIGNED
Ketogenic diets are a commonly used weight loss method, but little is known how variations in sodium content and ketones influence cognition and mood during the early keto-adaptation period.
Objectives UNASSIGNED
To investigate the effects of an exogenous ketone salt (KS) as part of a hypocaloric KD on mood and cognitive outcomes in overweight and obese adults. A secondary objective was to evaluate changes in biochemical markers associated with inflammatory and cognitive responses.
Materials and methods UNASSIGNED
Adults who were overweight or obese participated in a 6-week controlled-feeding intervention comparing hypocaloric diets (∼75% of energy expenditure). KD groups received twice daily ketone salt (KD + KS;
Results UNASSIGNED
Both KD groups achieved nutritional ketosis. Fasting serum glucose decreased in both KD groups, whereas glucose was unaffected in the LFD. Insulin decreased at week 2 and remained lower in all groups. At week 2, depression scores in the KD + PL group were higher compared to KD + KS. Performance in the math processing and go/no-go cognitive tests were lower for KD + PL and LFD participants, respectively, compared to KD + KS. Serum leptin levels decreased for all groups throughout the study but were higher for KD + KS group at week 6. Serum TNF-α steadily increased for LFD participants, reaching significance at week 6.
Conclusion UNASSIGNED
During a short-term hypocaloric diet, no indication of a consistent decline in mood or cognitive function were seen in participants following either KD, despite KD + PL being relatively low in sodium. WK2 scores of "anger" and "depression" were higher in the LFD and KD + PL groups, suggesting that KS may attenuate negative mood parameters during the early intervention stages.

Identifiants

pubmed: 36248655
doi: 10.3389/fnins.2022.971144
pmc: PMC9563373
doi:

Types de publication

Journal Article

Langues

eng

Pagination

971144

Informations de copyright

Copyright © 2022 Kackley, Brownlow, Buga, Crabtree, Sapper, O’Connor and Volek.

Déclaration de conflit d'intérêts

JV receives royalties for low-carbohydrate nutrition books; was founder, consultant, and stockholder of Virta Health, Inc. and was a member of the advisory boards for Simply Good Foods. MB and AO’C were employees of Metagenics. This study received funding from Metagenics, Inc. MB, AO’C. The funder contributed to the development of the supplement, placebo, and pilot study data. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.

Références

Med Sci Sports Exerc. 2008 Mar;40(3):535-41
pubmed: 18379218
Front Nutr. 2021 Mar 24;8:618520
pubmed: 33869263
Int J Mol Sci. 2014 Apr 11;15(4):6184-223
pubmed: 24733068
Lancet Neurol. 2020 Sep;19(9):758-766
pubmed: 32730766
Nutrients. 2021 Jan 26;13(2):
pubmed: 33530512
Metabolism. 1966 Sep;15(9):828-37
pubmed: 5929039
Am J Clin Nutr. 2006 May;83(5):1055-61
pubmed: 16685046
Nutrients. 2021 Mar 17;13(3):
pubmed: 33802651
Clin Neuropsychol. 2018 Apr;32(3):479-494
pubmed: 28832273
J Alzheimers Dis. 2018;64(2):551-561
pubmed: 29914035
Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S15-37
pubmed: 17276030
Dialogues Clin Neurosci. 2018 Mar;20(1):63-73
pubmed: 29946213
Arch Intern Med. 1963 Sep;112:333-7
pubmed: 14045276
Nutrients. 2021 Jun 05;13(6):
pubmed: 34198888
Am J Med. 2020 Aug;133(8):986-993.e5
pubmed: 32145210
Arch Clin Neuropsychol. 2005 May;20(3):403-8
pubmed: 15797175
Int J Mol Sci. 2020 May 02;21(9):
pubmed: 32370212
Qual Life Res. 2011 Sep;20(7):1111-21
pubmed: 21279447
Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1453-5
pubmed: 7952575
Medicine (Baltimore). 2016 Oct;95(43):e5260
pubmed: 27787389
Front Psychiatry. 2019 May 23;10:363
pubmed: 31178772
PLoS One. 2014 Nov 21;9(11):e113605
pubmed: 25415333
J Sports Sci Med. 2021 May 03;20(3):391-397
pubmed: 34267577
Epilepsia. 2015 Jul;56(7):e95-8
pubmed: 26011473
Brain Behav Immun. 2017 Jan;59:233-244
pubmed: 27633985
N Engl J Med. 2013 Aug 8;369(6):540-8
pubmed: 23924004
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1738-e1754
pubmed: 33367782
Nutr Res. 2019 Feb;62:64-77
pubmed: 30803508
J Immunol. 2005 Mar 15;174(6):3137-42
pubmed: 15749839
Dement Geriatr Cogn Disord. 2012;33(6):410-5
pubmed: 22814193
J Nutr Metab. 2018 May 22;2018:2630565
pubmed: 29951312
Nutrients. 2021 Sep 22;13(10):
pubmed: 34684300
Metabolism. 2002 Jul;51(7):864-70
pubmed: 12077732
Front Psychiatry. 2017 Mar 20;8:43
pubmed: 28373848
Mol Neurobiol. 2012 Aug;46(1):4-10
pubmed: 22205300
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217353
Trends Endocrinol Metab. 2014 Jan;25(1):42-52
pubmed: 24140022
Proc Natl Acad Sci U S A. 1918 Dec;4(12):370-3
pubmed: 16576330
Nutr Diabetes. 2017 Jun 19;7(6):e282
pubmed: 28628125
J Behav Med. 2022 Jun;45(3):416-427
pubmed: 35084637
Rev Neurol. 2019 Mar 1;68(5):190-198
pubmed: 30805917
Ther Apher Dial. 2020 Apr;24(2):169-177
pubmed: 31328395
Front Physiol. 2020 Sep 09;11:1094
pubmed: 33013465
Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9
pubmed: 6623350
Folia Biol (Krakow). 2014;62(4):301-6
pubmed: 25916157
Eur J Pharmacol. 2013 Nov 5;719(1-3):170-179
pubmed: 24070815
Alzheimers Dement. 2019 May;15(5):625-634
pubmed: 31027873
Pediatr Res. 1976 May;10(5):536-40
pubmed: 934725
Neurology. 2005 Feb 22;64(4):728-30
pubmed: 15728303
N Engl J Med. 2014 Aug 14;371(7):612-23
pubmed: 25119607
Clin Rehabil. 2018 Jan;32(1):94-102
pubmed: 28653547
Front Psychiatry. 2022 Jul 06;13:951376
pubmed: 35873236
Alzheimers Dement (N Y). 2017 Dec 06;4:28-36
pubmed: 29955649
Nutr Diabetes. 2020 Nov 30;10(1):38
pubmed: 33257645

Auteurs

Madison L Kackley (ML)

Department of Human Sciences, The Ohio State University, Columbus, OH, United States.

Milene L Brownlow (ML)

Research and Development Department, Metagenics Inc., Gig Harbor, WA, United States.

Alex Buga (A)

Department of Human Sciences, The Ohio State University, Columbus, OH, United States.

Chris D Crabtree (CD)

Department of Human Sciences, The Ohio State University, Columbus, OH, United States.

Teryn N Sapper (TN)

Department of Human Sciences, The Ohio State University, Columbus, OH, United States.

Annalouise O'Connor (A)

Research and Development Department, Metagenics Inc., Gig Harbor, WA, United States.

Jeff S Volek (JS)

Department of Human Sciences, The Ohio State University, Columbus, OH, United States.

Classifications MeSH